Minimal Residual Disease in multiple myeloma infographic
Important information
The following feature is intended for healthcare professionals only. Please tick the box below to confirm that you are a healthcare professional.
Minimal Residual Disease (MRD) is the low level of malignant cells that persist in the bone marrow after treatment but cannot be detected by conventional outcomes measures and which eventually lead to relapse. This infographic provides a visual snapshot of the importance of MRD in multiple myeloma.
OC Healthware infographic Myeloma (1) (2) (3)
The opinions expressed are of the contributor’s own and do not necessarily reflect the view of Oncology Central or Future Science Group.
Sponsored and funded by:
MAT-GLB-2300223 (1.0) 01/23